Health Care: Drugs

Immunoclin Corp (IMCL: OTC)

$2 n/a | n/a%
07/29/14 - 09:30 AM ET
Latest Dividend:0
Latest Dividend Yield:0%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
IMCLSector Avg.S&P 500
n/a028.85
Price Performance History (% change):
3 Mo1 Yr3 Yr
-46.666700
GROWTH12 Mo3 YrCAGR
Revenue00
Net Income00
EPS0n/a
Earnings for IMCL:
EBITDA-12.00
REVENUE0.00
Average Earnings Estimates
Qtr (12/08) Qtr (03/09) FY (12/08) FY (12/09)
Average Estimate $0.26 $0.28 $1.18 $1.39
Number of Analysts 8 1 8 9
High Estimate $0.30 $0.28 $1.26 $1.62
Low Estimate $0.21 $0.28 $1.03 $1.20
Prior Year $0.41 $0.33 $1.43 $1.18
Growth Rate (Year over Year) -36.89% -15.15% -17.83% 18.68%

Portfolios with IMCL

Latest IMCL Headlines from TheStreet

More Financial News for IMCL

Press Releases for IMCL

See All Press Releases

Partner Headlines for IMCL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter